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KAJIAN GENETIK VARIAN SLC2A9 DALAM POPULASI MELAYU 
TERHADAP GOUT  
ABSTRAK 
Gout adalah sejenis penyakit sendi yang terbentuk disebabkan oleh pengumpulan asid 
uric (berbentuk jarum) di bahagian sendi tertentu. Ianya berlaku apabila paras asid urik 
dan ketepuan fisiologi meningkat melebihi paras cecair dalam badan. Perkumuhan asid 
urik dalam buah pinggang dikawal oleh gen SLC2A9 yang bertindak sebagai pengangkut 
asid urik dan terlibat dalam pembentukan benjolan pada penyakit gout. Oleh sebab itu, 
objektif utama kajian ini adalah untuk menguji perkaitan empat varian genetik dalam gen 
SLC2A9 dan ciri-ciri demografi gout di kalangan populasi Melayu. Sampel-sampel darah 
diambil dari darah keseluruhan sebanyak 3 mililiter dan diekstrak menggunakan Qiagen 
Extraction Kit. Sementara itu, genotyping ke atas keempat-empat genetic varian yang 
diberi nama rs11942223, rs16890979, rs5028843 dan rs3733591 dijalankan dengan 
menggunakan Polymerase Chain Reaction-Restriction Fragment Length Polymorphism 
(PCR-RFLP). Purata kekerapan alel yang kecil (MAF) dan nisbah ganjil (OR) untuk 89 
sampel pesakit adalah 0.018 dan 4.374 dimana ia menunjukkan kuasa penyelidikan ini 
adalah sebanyak 80%. Keseimbangan Hardy-Weinberg dikira dengan menggunakan 
perisian program SHEsis yang menyediakan nisbah ganjil (OR) dan 95% confidence 
interval. Data kami mengesahkan peranan gen SLC2A9 terhadap kecenderungan ke atas 
gout dalam keturunan Melayu yang dilihat oleh kesan risiko (OR>2.0).  Alel minor 
rs3733591, rs1194223 dan rs5028843 mempengaruhi aktiviti SLC2A9 di dalam artikular 
kondrosit seterusnya meningkatkan risiko pemendapan kristal uric asid dan pembentukan 
xviii 
 
tophi. Secara keseluruhan, gabungan perkaitan haplotaip 1/2/1/1, 1/1/2/1 dan 1/1/1/2 di 
dalam kajian kami telah menunjukkan perkembangan risiko ke atas gout. 
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ABSTRACT 
Gout is an inflammatory arthritis that is caused by the formation of multiple needles 
like uric acid crystals in joints. It occurs when serum uric acid (SUA) levels rise and 
the physiological saturation is exceeded in body fluids. Renal urate excretion is 
controlled by the SLC2A9 gene which acts as a renal urate transporter and involves in 
the developing of tophaceous gout. Therefore the main objective of this study is to 
test genetic association of four common variants of SLC2A9 gene and demographic 
features of gout in Malay population. Blood samples were taken from 3ml whole 
blood according to Qiagen Extraction Kit and genotyping was conducted utilizing 
polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) 
method for 4 SNPs namely rs5028843, rs3733591, rs11942223 and rs16890979. The 
average Minor Allele Frequency (MAF) of 0.018 with OR of 4.374 requires 89 
samples of cases that project 80% power of study. Hardy Weinberg equilibirium was 
calculated by using SHEsis online software providing odd ratios and 95% confidence 
interval. Our data confirmed the role of the SLC2A9 gene of susceptibility of gout in 
the Malay descendents in Malaysian population which was seen by the effect of 
susceptible risk of (OR>2.0). Our study showed that the minor allele of rs3733591, 
rs1194223 and rs5028843 have influenced on the activity of SLC2A9 in articular 
chondrocytes increases the risk for deposition of MSU crystals and tophi formation. 
In summary, the association of 1/2/1/1, 1/1/2/1 and 1/1/1/2 haplotypes confer 
haplotypes which reflects the increase of gout development. 
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CHAPTER 1 
 
INTRODUCTION 
 
1.1    Research locale 
1.1.1 Background of the research 
Gout is an inflammatory arthritis that is linked with low quality of life (Roddy et 
al., 2007 and Lee et al., 2009). According to Niskanen et al., (2004), gout is a disease 
caused by the formation of multiple needles like uric acid crystals in joints.  
 
It occurs when serum uric acid (SUA) level rises and the physiological saturation 
is exceeded in body fluids. The formation of monosodium urate (MSU) crystals will 
occur in and around articular joints. The evidence in several studies had clearly shown 
the relation of uric acid levels with hypertension, inflammation, increased risk of 
cardiovascular disease and metabolic syndrome such as gout.  
 
The prevalence of gouty arthritis may vary depending on geographical area, race 
and gender. In the USA, the prevalence of gout increased from 2.9/1,000 in 1990 to 
5.2/1,000 in 1999 (Wallace et al., 2004). Epidemiological studies undertaken in UK 
suggested the prevalence of gout per 1,000 was 2.6 in 1975 (Currie, 1979), 3.4 in 1987 
and 9.5 in 1993 (Steven, 1992). In Asian countries, successive surveys had been taken in 
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China (Qingdao), which reported an increased trend from 3.6/1,000 in 2002 (Nan et al., 
2006) to 5.3/1,000 in 2004 (Miao et al., 2008). Previous reports have revealed the 
incidence of hyperuricemia and gout is higher in Asians who live in the USA compared 
to those groups living in their homeland. For instance, Filipinos who lived in Hong Kong 
or in the USA have significantly higher number of gouty patients than those living in 
their country of origin (Emmerson, 1983).  
 
In Malaysia, a developing country, there is a shortage of research and the limited 
studies being done are likely to be the same with other developing countries. Darmawan 
et al., 1992 reported that the environmental factors might also be one of the factors 
contributing to the manifestation of gouty arthritis. Based on gender, males are much 
more susceptible to gout than females and most of the cases occurred at the age of over 
40 years old. The onset of gout in female patients occurred at an older age in conjunction 
with menopause and was more frequently associated with renal sufficiency, diuretic 
therapy and monoarticular involvement (Chen et al., 1989). Estrogens in females have 
uricosuric effects, therefore gout is very rarely observed among younger females (Anton 
et al., 1986). 
 
Many drugs have been introduced to gouty patients which may increase or 
decrease the serum uric acid (SUA) levels. Allopurinol is the widely used drug for gout in 
the long term management. It reduces uric acid by inhibiting the enzyme of xanthine 
oxidase (XO) which is responsible for the production of urate (Stamp et al., 2010). 
However concurrent medications such as colchicines, non steroidal inflammatory agents 
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also need to be administered in the first three to six months to prevent gout flares due to 
the usage of allopurinol. 
 
Gout is a multifactorial disease caused by both environmental and genetic factors. 
Studies have implicated the excessive alcohol consumption, dietary and genetic factors 
showed association with the development of gout. In terms of genetic factors, many 
candidate genes and involved in the development of arthritis which includes SLC2A9, 
ABCG2, SLC22A12 and URAT1 gene (Tu et al., 2010).  
 
Polymorphisms in those genes have been observed to be associated with the 
susceptibility of gouty patients among European and Asian populations with comparable 
risk alleles between these populations (Tu et al., 2010). Contribution of various mutations 
was varied between different populations and it may be due to long-term activity of 
environmental factors and past events, such as immigration and endemic disease.  
 
In 2004, Portis and his colleagues (Portis et al., 2004) reported the incidence of 
gout is among aborigines, together with the adoption of a more Western lifestyle. For 
instance, the Hmong which is one of the Asian ethnic groups from the mountainous 
region of China, who started the migration after the Vietnam conflict in 1975 (Lemoine et 
al., 2005). Therefore, further research and studies on the combination between genetic 
and environmental factors are needed to enhance the better understanding towards 
molecular pathogenesis of gouty arthritis. 
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1.1.2 Rationale of the study 
There has been a growing interest in the studies of gouty arthritis in population 
worldwide (Nan et al., 2006). However the studies on the genetic association among 
Malay population are still lacking. Due to the lack of data, a case-control study was 
conceded in order to test the genetic associations within SLC2A9 gene in gouty arthritis 
among Malay population.  
This study was done based on the genome-wide association studies (GWAS) 
which have been carried out in worldwide populations such as Maori, Germany, Han 
Chinese, Caucasians and Sardinia Chianti cohorts (Li et al., 2007). GWAS is an active 
scanning marker of genomes which will select genetic variations associated with the 
selective disease. This scanning marker is useful in contributing to the better strategies of 
detecting and treating the particular disease once the genetic associations are initiated.  
Many candidate genes have been identified for several complex diseases (Moffatt 
et al., 2007), for instance gouty arthritis. Recent studies of GWAS have identified SNPs 
in a genomic region on chromosome 4. The ABCG2 gene and SLC2A9 gene are the two 
most common genes which interpose the regulation of uric acid synthesis (Yang et al., 
2005) and proved significant association with gouty arthritis and other complex 
metabolic diseases. Thence, this study was conducted to replicate the GWAS analysis 
which have been done on several population studies and compared with the Malay 
population. It is hoped that this apprentice study in Malaysia will provide evidence from 
association to causation on the etiology of gout. 
 
5 
 
1.1.3 Objectives 
1.1.3.1 General objective 
To test the genetic association of four common variants of SLC2A9 gene and 
demographic features of gout in Malay population 
1.1.3.2 Specific objectives 
1. To determine the association of demographic data (age, BMI and family history) with 
serum urate level 
2. To determine single association of SLC2A9 single nucleotide polymorphisms with 
gout development 
3. To determine the role of haplotype in gouty arthritis 
4. To identify other possible variants within SLC2A9 gene using fine mapping approach 
in Haploview software. 
 
1.2 Genetics of metabolic syndrome 
1.2.1 Metabolic syndrome 
The Metabolic syndrome (MetS) is defined by the grouping of cardiovascular risk 
factors and caused an increased mortality for cardiovascular disease (Zimmet et al., 
2005). This grouping has been said to be as “Syndrome X, the deadly quartet, and the 
insulin resistance syndrome”. It has been reported that insulin resistance is a reason that 
caused the abnormal pathophysiologic condition (Tsouli et al., 2006). Multiple studies 
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have initiate that individuals with metabolic syndrome are at an increased chance of 
getting cardiovascular diseases (Grundy et al., 2005 and Wilson et al., 2005). 
 
Hyperuricemia reflects insulin resistance (Carnethon et al., 2003; Coasta et al., 
2002). Increased serum uric acid levels which subsequently cause gout often comes 
together with obesity, dyslipidemia, and hypertension. In Taiwanese adults, it has been 
reported that there is an encouraging association between metabolic syndrome and serum 
uric acid level (Lohsoonthorn et al., 2006) but little information for the Malaysian adults 
is available.  
Subsequently, several criteria were used in addition with World Health 
Organization (WHO) as to identify individuals who have the risks namely, the National 
Cholesterol Education Program Expert Panel III (ATP III) and the International Diabetes 
Federation (IDF) (Alberti et al., 2006). Table 1.1 shows the criteria proposed for 
common clinical diagnosis which are insulin resistance, body weight, lipid, blood 
pressure, glucose and others of the clustered syndrome.  
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Table 1.1: Criteria Proposed for Clinical Diagnosis of the Metabolic Syndrome 
Clinical 
measure 
WHO (1998) NCEP/ATP III 
(2001) 
IDF (2005) 
Insulin 
resistance 
IGT, IFG, T2DM or 
low insulin sensitivity, 
plus any two of the 
following 
 
None but any three 
of the following 
features 
None 
Body weight  Males: waist to hip 
ratio >0.90; females : 
waist to hip ratio >0.85; 
and/or BMI >30kg/m
2 
 
WC >102cm in men 
or > 88cm in women  
Increased WC 
(population 
specific) plus any 
two of the following 
Lipid TG> 150mg/d L and/or 
HDL-C<35mg/d L in 
men or <39mg/d L in 
women. 
 
TG>150mg/d L TG>150mg/d L  
Blood pressure >140/90mm/Hg >130/85mm/Hg >130mm/Hg 
systolic  
 
 
Glucose  IGT, IFG, or T2DM >110 mg/dL 
(includes diabetes)‡ 
 
>100 mg/dL 
(includes diabetes) 
Other Microalbuminuria 
 
  
 Abbreviations: 
IGT=Impaired glucose tolerance  TG=Triglyceride 
WC=Weight code    IFG=Impaired fasting glucose 
HDL=High Density Lipoprotein  T2DM=Type 2 diabetes mellitu 
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Based on WHO, ATP III and IDF deﬁnitions, the prevalence of MetS among the 
Malaysian adults was 32.1, 34.3 and 37.1%, respectively.  Regardless of the deﬁnition 
used, Malaysia seemed to record a higher prevalence compared to other Asian countries, 
such as India (Deepa et al., 2007), Hong Kong (Ko et al., 2006) and China (Gu et al., 
2005) where prevalence ranged from 6.1 to 18.3%, when based on ATP III deﬁnition, and 
increased to 9.6 to 25.8%, when data were analyzed using IDF criteria. The numbers 
observed in Malaysians was similar to other non-Asian populations, such as the United 
States (34.4%) and in Iran (35.6%) (Ervin et al., 2009). 
Despite the higher prevalence rates of MetS in Malaysia when compared to other 
Asian countries, studies on various populations in Malaysia itself are still scarce 
(Mohamud et al., 2010). In Europe, the prevalence rates of metabolic syndrome have a 
range of 20-30% (Qiao, 2006 and Grundy, 2008) whereas the prevalence rates among 
migrant Asians have a range of 14-49% (Misra and Khurana, 2009). 
 
1.2.2 Pathophysiology of metabolic syndrome 
The metabolic reaction of cellular, chemical and soluble protein components in 
the human metabolism play a fundamental role to maintain normal body functions. 
However, the pathogenesis of metabolic syndrome remains unclear (Eckel et al., 2005).  
Tumor necrosis factor-𝛼 (TNF- 𝛼) is the best candidate to correlate with 
metabolic syndrome abnormalities. This multifunctional cytokine has been suggested to 
lead to the production of proinflammatory cytokine but is also trigger cell signaling by 
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interaction with a TNFα receptor. This in return leads to insulin resistance (Fukuchi et al., 
2004). Increase of adipose tissue leads to increase of immune cells and play a part in 
inflammation.  
 Inflammation which includes redness and an increased local supply of white 
blood cells is the body's response to injury. The purpose is to defend against infections 
and repair damaged tissue. The incident of having chronic inflammation will contributes 
to an increased risk of gout and several other MetS which are hypertension, 
artherosclerosis and diabetes (Whitney et al., 2011).  
 
1.2.3 Risk factors of metabolic syndrome 
MetS has becoming more common in Asian and the United States. The etiology 
of the progression of metabolic syndrome is complex (Figure 1.1) and is determined by 
the interaction of both genetics and environmental factors. 
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Figure 1.1: The pathophysiology of atherosclerotic cardiovascular diseases in the metabolic 
syndrome. Common genetic variants and environmental factors may lead to the development of 
atherosclerosis by affecting central adiposity, innate immunity, glucose and lipoprotein 
metabolism, and vascular function. BP = blood pressure; HDL= high-density lipoprotein; TG 
=triglycerides (American Heart Association, 2006). 
 
\ 
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1.2.3.1 Environmental factor interaction 
MetS has been classified as a lifestyle disease. Its prevalence is increasing 
worldwide as a consequence of the obesity epidemic. The two most significant risk 
factors that contribute to the disease is central obesity (extra weight around the middle 
and upper parts of the body) (Fauci et al., 2008) and also the insulin resistance (body uses 
insulin effectively than normal insulin) (Misra et al., 2009). 
Based on the World Health Organization (http://www.who.int), approximately 1 
billion adults are overweight (body mass index > 25 kg/m
2
), and 300 million of these are 
considered clinically obese (body mass index > 30 kg/m
2
). The identification of an 
overweight person is identified by a person with having too much fat, extra muscle and 
water. Other risk factors that topped the list are aging at where the MetS affect 44% of 
the US population more than the age of 50. Women are prone to have an increased risk of 
having the syndrome rather than men in most populations (Fauci et al., 2008). 
Thus, the factors contributing to recent changing patterns in MetS prevalence in 
most of geographic region may provide interesting insights into tackling the ever burden 
of cardiovascular risk.  
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1.2.3.2 Genetic factor interaction 
In addition to these environmental factors, the genetic component in the 
pathogenesis of the MetS has also been investigated. Genetics components have been 
included as a risk factor to understand the genotype-phenotype interactions of this 
syndrome. These genetic variants may act in accordance with other variants and 
environmental factors.  
 
1.2.4 Genetic analyses in metabolic syndrome 
Seevral evidence suggests that metabolic syndrome is the result of the relationship 
between several genes and prosperous environment. It is apparent that all components in 
the syndrome are strongly inherited. 
 
1.2.4.1 Application of genomewide scan and association approaches for complex 
human diseases 
 
Genomewide scan is an application to locate for genetic loci that gives effect to 
human diseases (Wiggs et al., 2000). Through this application, the genetic regions will be 
easily localized with regards to the disease-predisposing genes (Wray et al., 2013). 
Firstly, the chromosomal region will be identified whether it is linked to the 
disease or not, later on the linkage disequilibrium (LD) mapping will be carried out to 
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constrict down the region of interest. The identification of the genes and the variants that 
cause MetS is conducted by positional cloning without influencing the biologic role of 
the gene.  
 
The susceptibility of the candidate genes can also be tested using the association 
studies. Genes are selected based on its potential role towards the pathogenesis of its 
variant or its location within a region of interest in the gene which identified by the 
screening of genome wide scan linkage. Basically, the association studies are being done 
based on genetic variation. Genetic variation has been described as a genetic difference 
among individuals of the same species (Barrett et al., 2008). Mating patterns, genetic 
drift and migration are the reasons that lead to the increased and decreased genetic 
variation (Keinan et al., 2007). 
 
Mating patterns are mostly referred to non random mating due to most organisms 
choose to mate based on certain characteristics. There are two forms of non random 
mating which are inbreeding and outbreeding. Inbreeding happens to mate together with 
similar genotypes rather than with different genotypes (Keller et al., 2002). On the other 
hand if there is an increased chance for the individuals with certain genotypes to mate 
with another particular genotype it is called outbreeding.  
 
Other than this, genetic drift can also occur by changing the relative allele 
frequency in a population. This phenomenon can increase or decrease over time. 
Population bottleneck in a genetic drift happens when a group of individuals in a 
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population pass away which are avoided from mating. This in return will lead to drastic 
decrease of population sizes (Parmesan, 2006). Genetic drift plays an impart role in the 
species evolution because it result in the loss of rare alleles and the size of the gene pool 
decrease will cause a new population to be different in original later on (Hallatschek et 
al., 2010). 
 
Lastly is the incidence of migration. Migration is referred to the movement of 
organisms to different location, which often means the movement of individuals into or 
out of a certain population. Sudden changes of alleles can happen if the migrating 
individuals stay and mate with the individuals in the new location (International HapMap, 
2010) 
 
1.2.4.2 Interpretation of genetic association studies and detection using GWAS 
(Genomewide Association Study). 
 
The field of genetics serves as one of the most powerful and straight approach to 
explore the basis of human disease. The genetic approaches have led to recognition of 
variations in human genome based on single-nucleotide polymorphisms (SNPs). The 
identified variations allow the GWAS to recognize any significant relationship between 
genetic and clinical aspects. This in turn triggers a cascading reaction of clinical 
treatment based on the markers used for diagnosis and prognosis of the said disease. 
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GWAS is capable to generate large sample sets of potential genes that are 
believed to have functional significance on the manifestation of a disease (Yamamoto and 
Yamada 2007) and screening thousands of SNPs in the genome at a time. These studies 
are now common and are beginning to identify regions which contain disease 
susceptibility loci (Lowe et al., 2007). 
 
The primary step of GWAS is by localizing the likely candidates of causal 
variants which will be validated subsequently perform the re-sequencing to identify 
polymorphisms in the associated region and to search the LD within the region. So 
genotyping is vital in order to localize the associated polymorphisms in the disease. 
Accurate and precise identification will lead to statistically powerful investigations 
between genotype and phenotype correlations (Lowe et al., 2007). 
 
However there are several reasons suggesting that most of the findings reported 
on associations are inaccurate (Ioannidis et al., 2001). The main reasons for this include 
inadequate sample size, genetic heterogeneity of human populations, nature of the illness 
and associated presence of confounding risk factors (Kruglyak et al.2001).  
 
Some SNPs are functional, which may raise or reduce the risk of illness than 
others. Functional SNPs, including missense coding SNPs and non exonic regulatory 
SNPs,that might be implicated in splicing mechanism are more likely to be evolutionarily 
deleterious or beneficial. There are many more unknown variants expected to contribute 
to general diseases. Therefore, the discovery of the disease associated with genetic 
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variants and their basic biologic pathways is not an easy task, and is a main obstacle in 
human genetic studies (Barnes et al., 2007). 
1.3 Gouty arthritis 
1.3.1 Definition of gouty arthritis 
Gout is an inflammatory arthritis that has risen in prevalence for recent decades 
(Roddy et al., 2007). This prevalent metabolic disorder is characterized by chronic 
hyperuricaemia, a condition of elevated serum uric acid (SUA) levels (>6.8 mg/dL or 
≥360 mmol/L) (Terkeltaub, 2010). The increment of SUA levels can result in the 
formation of monosodium urate monohydrate crystals (tophi). It is deposited in the soft 
tissues in and around the joints, thus invigorating an inflammatory response (Terkeltaub 
et al., 2010 and Wortmann et al., 2002). This in turn will lead to acute arthritis with 
severe pain, most commonly affecting the mobility (Mclean et al., 2003). The articular 
and peri-articular inflammation in chronic gout can lead to the degradation of osseous 
tissue (Figure 1.2) and the most commonly affected region is at the base of the big toe. 
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Figure 1.2:  Radiograph of gout in human foot as shown in rectangular box showed 
damage to the osseous tissue. This image suggests a significant relationship between the 
presence of the gouty tophus and bone erosions in asymptomatic chronic tophaceous 
gouty arthritis on high resolution ultrasonography. It is the eroding tophus that is crucial 
for the development of bone erosions in gouty arthritis (Dalbeth et al., 2014). 
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The gold standard of diagnosing gouty arthritis is to make obvious the incidence 
of monosodium urate monohydrate (MSU) crystals in synovial fluid when the patient was 
combating the attack (Wallace et al., 2004). Janssens et al. (2010) reported that the 
synovial fluid analysis was rarely being performed by them to demonstrate the presence 
of urate crystals due to the lack of expertise itself to demonstrate and limitation of access 
to the polarizing microscope.  
Synovial fluid examination has become the best practice in clinical settings; 
however it may not be practical especially given the incidence of gout and massive 
sample size that are required within the population researches. Besides that, if we were to 
look up in several studies, the terms such as gout flare, chronic gouty and also acute 
gouty be frequently being used, but to the best of our knowledge it seemed to be that 
these terms have been differently used by different authors. Therefore, in order to aid the 
study results, reasonable clarification variety of manifestations and stages of the disease 
may require. 
 
1.3.2 Epidemiology of gout 
Gouty arthritis, which is considered as a metabolic syndrome is the major health 
problem and the number is increasing worldwide. It is reported that around 20-25% of the 
population in the world has metabolic syndrome (Alberti et al., 2006) and the prevalence 
differs according to geographic location, nationality, population characteristics and the 
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criteria of metabolic syndrome itself  (Huang and Jayakar, 2010 and Romaguera et al., 
2010). Malaysia has been listed as the top ten countries with the highest prevalence of 
metabolic syndrome such as gout and diabetes mellitus (Shaw et al., 2010).  
If based on genders, previous studies have originated with the intention of 
metabolic syndrome with uric acid was higher among men than women in Americans 
with (35.1% versus 32.6%) (Erum, 2009), Europeans (32.2% versus 28.5%) (Qiao, 
2006), Malaysian (54.7% versus 45.3%) (Moy and Bulgiba, 2010), Koreans (21.7% 
versus 11.4%) (Hwang et al., 2009), and Japanese (11.6% versus 4.0%) (Kuzuya et al., 
2007). Figure 1.3 shows the prevalence rates in UK for gout patients that are 
predominant in men. 
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Figure 1.3: Prevalence of gout in the UK based on gender and age. The graph showed that 
gout is mainly a disease of older men in the UK. Gout is apparent in women after the menopause 
(Mikuls et al., 2005). 
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The epidemiological connecting hyperuricemia and gout was recognized over 150 
years ago with an increasing prevalence particularly in the elder age group. In the United 
States, the prevalence of gout in the US population after the age of 75 years of old 
between the year 1990 and 1999, the increased from 21 per 1000 to 41 per 1000 
population (Wallace et al., 2004). A year later, a second study conducted in the United 
Kingdom in an adult population, estimated over 7% at the age of 75 years old developed 
gout (Mikuls et al., 2005). The same tendency has been found in the studies in China (Lin 
et al., 2006 and Yoo et al., 2005) with the proof in Qingdao, China in which the increase 
of gout has been reported as an increase trend from 3.6/1000 in 2002 (Nan et al., 2006) to 
5.3/1000 in 2004 (Miao et al., 2008). It is indeed still hard to draw a clear cut of 
statistical epidemiology of gout among the Malays since more information and studies 
are needed to enhance the better understanding of the pathogenesis and epidemiology of 
gout. 
 
1.3.3 Symptoms and clinical aspects of gout 
Gout has been recognized as the most readily amendable of all common systemic 
rheumatic disease (Bieber et al., 2004) leading to joint destruction and disability if 
untreated (Sundy et al., 2007). It is basically an acute inflammatory monoarthritis 
generally lead to the great toe metatarsal phalangeal (MTP) joint (Cameron et al., 2005) 
which is known as podagra. Besides toe, other joints affected are ankle, knee and wrist. 
The development of rigorous pain and tenderness of gout reach in 6-24 hours of onset 
and will spontaneously resolve within several days to two weeks. The extensive of first 
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attack commonly affected a single joint but oligo-articular and polyarticular gout can 
happen markedly in the older patient (De Leonardis et al., 2007). 
The metabolic disorder of gouty arthritis can elevate serum uric acid level that for 
years before an actual gouty attack occurs. The excessive of uric acid will lead to the 
development of monosodium urate (MSU) crystals which can be seen in Figure 1.4, and 
subsequently caused formation of tophi. A vascularity of connective tissues, especially 
the cartilage, is believed to be the major predisposing factor for the deposition of urate. 
Nevertheless, the MSU crystals may also be deposited in the synovial membrane, 
particularly when the inflammation occurs (Dalbeth et al., 2008). 
 
 
 
 
 
23 
 
 
Figure 1.4: Findings of gout for MSU crystals under a polarizing microscope. A section has 
been stained with nonaqueous alcoholic eosin staining (NAES) to demonstrate birefringent 
crystals in gout (Shidham et al., 2001). 
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Tophus (singular: tophi) which is composed of MSU crystals in matrix of lipids, 
protein and mucopolysaccharides are known as the trademark of chronic gout and occurs 
inside subcutaneous tissues and the joints. Dalbeth et al. (2010) reported that tophus are 
usually non delicate, however it may cause mechanical obstructions of joint movement 
and muscoskeletal disability. This is in accordance with the study done by Thiele et al. 
(2005), tophi will grow mutely for years and demonstrated by the ultrasonographic 
“double contour sign” (a thin coating of monosodium urate (MSU) on the surface of 
cartilage) in asymptomatic joints. 
The basis of criteria to assess the prevalence of gout in epidemiologic studies has 
been described since 1960 to ease the rheumatologists in classifying the disease. In 1963, 
the Rome criteria were proposed during a symposium on population studies, (refer to 
Table 1.2). This criteria together with the New York’s; which are the adjustment of the 
Rome criteria and are based on the expertise, intended for the application of 
epidemiologic studies (Johnson et al., 2007). The criteria heavily leaned on the presence 
of tophi and the detection of MSU crystals in synovial fluid. This gives reason why both 
criteria sets are barely used in the large epidemiologic studies. 
 
 
 
 
 
